NR Clinical trial Archives » LongevityFacts

Anti-Aging Science
New NR Vitamin Promising to Address Aging in Adults

By Brady Hartman on March 29, 2018

Summary: Nicotinamide riboside (NR), a form of vitamin B, increased levels of NAD report researchers in a new study. [This article first appeared on LongevityFacts and was updated on April 3, 2018. Author: Brady Hartman. ] Researchers at the University of Colorado Boulder (UCB) reported that nicotinamide riboside (NR) – a unique form of B vitamin – increased levels of NAD, in a clinical trial of… Continue reading "New NR Vitamin Promising to Address Aging in Adults"
Anti-Aging Science
Revolutionary Technologies to Beat Aging in Our Lifetimes

By Brady Hartman on February 3, 2018

Five technologies in development – including senolytic drugs, rapamycin, stem cell therapy, NAD supplementation and gene therapy – could dramatically slow down aging in the next few years. This report updates the latest developments in these promising and potentially lifespan-extending treatments. [This article first appeared on the website LongevityFacts. Author: Brady Hartman. ] The longevity science field has made enormous progress in recent years,… Continue reading "Revolutionary Technologies to Beat Aging in Our Lifetimes"
Anti-Aging Science, Healthy Living
Researchers report promising pterostilbene and NR clinical trial results

By Brady Hartman on January 30, 2018

A clinical trial of an NR and pterostilbene anti-aging supplement appeared to be safe over the short-term as it increased NAD levels in a sustained way. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ] A clinical trial of NR and pterostilbene sustainably increased NAD levels and appeared to be safe over the short-term. Moreover, the study suggests that it increased… Continue reading "Researchers report promising pterostilbene and NR clinical trial results"

Tag: NR Clinical trial

New NR Vitamin Promising to Address Aging in Adults

Revolutionary Technologies to Beat Aging in Our Lifetimes

Researchers report promising pterostilbene and NR clinical trial results